1. Consulting on Common Concerns in PAH: How Would You Manage These Patients?

2. Program Themes

3. 52-Year-Old Man, Diagnosed With PAH in 2012

4. RHC

5. Initial Visit at Specialty Clinic 2015

6. Pharmacist's Role, Initial Management

7. Case Study: Escalation of Therapy Indicated

8. Classes of Agents That Target Different Pathways in PAH

9. Combination Pharmacotherapy in PAH: Rationale and Potential Clinical Benefits

10. AMBITION Study: Primary Endpoint* Results

11. Tactics to Address Treatment Adherence

12. Tactics to Address Treatment Adherence (cont)

13. Follow-Up: 3 Months

14. Follow-Up 2 Years Later

15. Objective Findings at 1 Year

16. Pharmacist's Role Transition to Oral Prostacyclin Pathway Agent

17. Parenteral Therapies: Multidisciplinary Collaboration and Specialty Pharmacies

18. Multidisciplinary Collaboration

19. Conclusions

20. Abbreviations

21. Abbreviations (cont)